1. Home
  2. FULC vs NEWT Comparison

FULC vs NEWT Comparison

Compare FULC & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

N/A

Current Price

$3.69

Market Cap

281.1M

Sector

Health Care

ML Signal

N/A

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

N/A

Current Price

$9.79

Market Cap

310.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FULC
NEWT
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
310.9M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
FULC
NEWT
Price
$3.69
$9.79
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$3.67
★ $15.20
AVG Volume (30 Days)
★ 1.2M
234.9K
Earning Date
11-12-2026
10-28-2026
Dividend Yield
N/A
★ 7.68%
EPS Growth
N/A
★ 11.22
EPS
N/A
★ 1.24
Revenue
N/A
N/A
Revenue This Year
N/A
$3.59
Revenue Next Year
N/A
$11.00
P/E Ratio
★ N/A
$7.97
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$9.86
52 Week High
$15.74
$15.69

Technical Indicators

Market Signals
Indicator
FULC
NEWT
Relative Strength Index (RSI) 45.53 30.92
Support Level $3.62 N/A
Resistance Level $3.81 $11.61
Average True Range (ATR) 0.06 0.32
MACD -0.00 -0.09
Stochastic Oscillator 7.69 1.36

Price Performance

Historical Comparison
FULC
NEWT

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About NEWT NewtekOne Inc.

NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.

Share on Social Networks: